Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of IP GM-CSF, Fosfomycin, and Metronidazole in Uncomplicated Appendicitis
NCT03046758Phase 2Completed
- Sponsor
- Herlev Hospital
- Start
- Feb 2017
- Primary completion
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fosfomycin, metronidazole, sargramostim in appendicitis, sponsored by Herlev Hospital. Started Feb 2017; status: completed.
02
Drugs
fosfomycinmetronidazolesargramostim
03
Conditions
appendicitis
Beyond the preview
Go deeper on NCT03046758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03046758.